Lisby Steen 4
4 · Y-mAbs Therapeutics, Inc. · Filed Apr 28, 2022
Insider Transaction Report
Form 4
Lisby Steen
Sr VP & CMO
Transactions
- Award
Employee Stock Option (right to buy)
2022-04-26+20,000→ 20,000 totalExercise: $9.51Exp: 2032-04-26→ Common stock (20,000 underlying)
Footnotes (2)
- [F1]Stock options granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
- [F2]The stock options shall vest and become exercisable as to 50% of the shares subject to the options on April 26, 2023 and as to the remaining 50% of the shares subject to the options on April 26, 2024, subject to the continuing employment of the Reporting Person on each vesting date.